Georgiamune
Signal active
Organization
Contact Information
Overview
Georgiamune is an immunotherapy company focused on oncology breakthroughs. The company employs next-generation immunotherapeutic and homeostatic therapies for cancer and autoimmune illnesses, allowing patients to recover quickly from cancer.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2014
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Georgiamune headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $1.8B in funding across 24 round(s). With a team of 11-50 employees, Georgiamune is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Georgiamune, raised $75.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
7
Lead Investors
0
Total Funding Amount
$75.0M
Details
1
Georgiamune has raised a total of $75.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 75.0M |
Investors
Georgiamune is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Ayman AlAbdallah | - | FUNDING ROUND - Ayman AlAbdallah | 75.0M |
| Mubadala Capital Ventures | - | FUNDING ROUND - Mubadala Capital Ventures | 75.0M |
| Georgiamune | - | FUNDING ROUND - Georgiamune | 75.0M |
| Bioventures Investors | - | FUNDING ROUND - Bioventures Investors | 75.0M |
Recent Activity
There is no recent news or activity for this profile.